EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From Polymorphisms to Phenotypes: SMAD3 rs17293632 and LTBP3 rs11545200 in Pediatric Inflammatory Bowel Disease

Jan Brylak iD, Mariusz Szczepanik, Jan K Nowak iD, Małgorzata Jamka iD, Aleksandra Glapa-Nowak iD, Aleksandra Banaszkiewicz, Andrzej Radzikowski, Anna Szaflarska-Popławska, Jarosław Kwiecień iD, Urszula Grzybowska-Chlebowczyk, Edyta Kawałkowska, Anna Wiernicka iD und 1 weitere

Genes · 2025

DOI: 10.3390/genes16121511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Jan Brylak und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, 60-572 Poznan, Poland. Hauptthemen laut MEDLINE: Smad3 Protein, Polymorphism, Single Nucleotide, Latent TGF-beta Binding Proteins, Crohn Disease. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Early-onset inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), frequently presents with a more severe clinical course. Genetic susceptibility, particularly involving the TGF-β signaling pathway, plays a key role in IBD pathogenesis. SMAD3 and LTBP3 encode crucial components of this pathway and have been implicated in IBD in previous genome-wide association studies.

Methods

This study aimed to assess the clinical significance of the rs17293632 (SMAD3) and rs11545200 (LTBP3) polymorphisms in a pediatric IBD cohort. A total of 286 children (133 with UC and 153 with CD) were recruited from seven pediatric centers in Poland. Clinical data included age at diagnosis, inflammatory markers (CRP, albumin), growth indices (Z-scores for weight, height, and BMI), and treatment regimens.

Results

The LTBP3 rs11545200 minor allele was significantly associated with a younger age at diagnosis, poorer nutritional status during disease flares, and a more frequent use of infliximab—particularly in patients with UC. In CD, the SMAD3 rs17293632 major homozygous genotype was associated with increased use of systemic corticosteroids, suggesting a more severe or treatment-resistant disease phenotype.

Conclusions

The assessed polymorphisms in LTBP3 and SMAD3, both involved in TGF-β signaling, are associated with clinical characteristics of pediatric IBD. These findings support the potential role of genetic variants as biomarkers for disease severity and treatment tailoring, contributing to the development of personalised therapeutic strategies in children with IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smad3 ProteinPolymorphism, Single NucleotideLatent TGF-beta Binding ProteinsCrohn DiseaseInflammatory Bowel DiseasesColitis, UlcerativeHumansMaleFemaleChildAdolescentGenetic Predisposition to DiseasePhenotypeChild, Preschool

Stichwörter der Autor:innen

Crohn’s diseaseLTBP3SMAD3TGF-βinflammatory bowel diseasepediatricsulcerative colitis

Substanzen

Smad3 ProteinSMAD3 protein, humanLatent TGF-beta Binding Proteins

Autor:innen und Institutionen

  • Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, 60-572 Poznan, Poland.
  • Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, 02-091 Warsaw, Poland.
  • Department of Pediatric Endoscopy and Gastrointestinal Function Testing, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-094 Bydgoszcz, Poland.
  • Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
  • Department of Pediatrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland.
  • Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.

ORCID-Profile: Jan Brylak, Jan K Nowak, Małgorzata Jamka, Aleksandra Glapa-Nowak, Jarosław Kwiecień, Anna Wiernicka, Jarosław Walkowiak

Zitieren

APA

Brylak, J., Szczepanik, M., Nowak, J. K., Jamka, M., Glapa-Nowak, A., Banaszkiewicz, A., Radzikowski, A., Szaflarska-Popławska, A., Kwiecień, J., Grzybowska-Chlebowczyk, U., Kawałkowska, E., Wiernicka, A., & Walkowiak, J. (2025). From Polymorphisms to Phenotypes: SMAD3 rs17293632 and LTBP3 rs11545200 in Pediatric Inflammatory Bowel Disease. Genes. https://doi.org/10.3390/genes16121511

Vancouver

Brylak J, Szczepanik M, Nowak JK, Jamka M, Glapa-Nowak A, Banaszkiewicz A, et al. From Polymorphisms to Phenotypes: SMAD3 rs17293632 and LTBP3 rs11545200 in Pediatric Inflammatory Bowel Disease. Genes. 2025. doi:10.3390/genes16121511

BibTeX
@article{Brylak2025,
  author = {Brylak, Jan and Szczepanik, Mariusz and Nowak, Jan K and Jamka, Małgorzata and Glapa-Nowak, Aleksandra and Banaszkiewicz, Aleksandra and Radzikowski, Andrzej and Szaflarska-Popławska, Anna and Kwiecień, Jarosław and Grzybowska-Chlebowczyk, Urszula and Kawałkowska, Edyta and Wiernicka, Anna and Walkowiak, Jarosław},
  title = {From Polymorphisms to Phenotypes: SMAD3 rs17293632 and LTBP3 rs11545200 in Pediatric Inflammatory Bowel Disease},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16121511}
}
Kostenlos starten →